EUVIMEDEUVIMED entdecken
Crossref

Comparative Circulating Biomarkers in Hereditary Ovarian Cancer and Lessons from Animal Models: A Review

Aliyu Hussaini, Abba Musa, Huzaifa Abdullahi, Salim Aliyu Abbas, Abdulrahman Abdulkadir Maishanu

Pertanika Journal of Veterinary Medicine and Science · 07.07.2026

DOI: 10.47836/pjvms.1.1.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pertanika Journal of Veterinary Medicine and Science, online erschienen am 07.07.2026. Verfasst von Aliyu Hussaini und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary ovarian cancer is often treated as a distinct clinical entity within epithelial ovarian malignancies because a substantial proportion of cases arise in the setting of germline pathogenic variants most notably in BRCA1 and BRCA2. Even with wider access to genetic testing and the routine use of risk-reducing strategies, early detection of high-grade serous carcinoma (HGSC) remains difficult in practice. The usual screening tools such as serum CA125 and transvaginal ultrasonography are frequently discussed as options for surveillance, yet they have not shown the level of sensitivity and specificity needed for confident detection of early-stage disease, especially in asymptomatic high-risk carriers. In response, multiple circulating biomarker classes have been explored, including circulating tumor DNA (ctDNA), cell free DNA (cfDNA) methylation signatures, microRNAs, and extracellular vesicles, sometimes combined as multi-analyte panels. These approaches are appealing because they could capture tumor-associated molecular signals before a lesion becomes radiologically apparent. Still, the size of the signal in early disease is likely small, and clinical translation has been slower than early enthusiasm might suggest. Preclinical systems particularly genetically engineered mouse models and comparative oncology approaches offer a way to follow biomarker dynamics across defined stages of tumor development and to test analytic methods under controlled conditions. This review synthesizes evidence on circulating biomarkers in hereditary ovarian cancer and examines how animal models can clarify biomarker timing, translational relevance, and methodological limitations.

Zitieren

APA

Hussaini, A., Musa, A., Abdullahi, H., Abbas, S. A., & Maishanu, A. A. (2026). Comparative Circulating Biomarkers in Hereditary Ovarian Cancer and Lessons from Animal Models: A Review. Pertanika Journal of Veterinary Medicine and Science. https://doi.org/10.47836/pjvms.1.1.004

Vancouver

Hussaini A, Musa A, Abdullahi H, Abbas SA, Maishanu AA. Comparative Circulating Biomarkers in Hereditary Ovarian Cancer and Lessons from Animal Models: A Review. Pertanika Journal of Veterinary Medicine and Science. 2026. doi:10.47836/pjvms.1.1.004

BibTeX
@article{Hussaini2026,
  author = {Hussaini, Aliyu and Musa, Abba and Abdullahi, Huzaifa and Abbas, Salim Aliyu and Maishanu, Abdulrahman Abdulkadir},
  title = {Comparative Circulating Biomarkers in Hereditary Ovarian Cancer and Lessons from Animal Models: A Review},
  journal = {Pertanika Journal of Veterinary Medicine and Science},
  year = {2026},
  doi = {10.47836/pjvms.1.1.004}
}
Kostenlos starten →